Advertisement
Screener

Lantern Pharma Inc. (LTRN) Stock Issued During Period, Value, Issued for Services

1.9 / 5 stars · 13/34 Roast Me

Lantern Pharma Inc. Stock Issued During Period, Value, Issued for Services

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Lantern Pharma Inc. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $38.80K.
  • Lantern Pharma Inc. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $134.10K.
  • Lantern Pharma Inc. stock issued during period, value, issued for services for fiscal 2025 was $366.90K.
Period endStock Issued During Period, Value, Issued for Services 3 monthStock Issued During Period, Value, Issued for Services 12 month
2026-03-31$38.80K
10-Q · filed 2026-05-15
2025-12-31$366.90K
10-K · filed 2026-03-30
2025-09-30$134.10K
10-Q · filed 2025-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
Korsana Biosciences, Inc. (CYCN)United States$0.016B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13